Peter James Arthur Benson

Danmarks Eksport- og Investeringsfond (EIFO) is a venture capital subsidiary of Government of Denmark and founded in 1992. The firm is headquartered in Hellerup, Denmark.

Azanta Danmark A/S operates as biopharmaceutical company developing treatments for women's health indications and for orphan oncology. The firm develops protein therapeutics within oncology and infectious diseases. The company was founded by Martin N. Bonde, Jens Christian Jensenius, Steffen Thiel, and R. Alan B. Ezekowitz in 2000 and is headquartered in Valby, Denmark.

Alsensa is a Danish-based Medical Device Research and Development, Design and Pilot-Scale manufacturing company. Alsensa's first Pilot-Scale product was the AQT all-in-one allergy testing device that will bring a new standard to antiquated Skin Prick Testing procedures. Alsensa has recently expanded the intended use of its primary product to include drug delivery applications. This product, currently under development stands to revolutionize the drug self-injection market.

Life Science Ventures provides financial advice.

Asante Solutions, Inc. operated as a medical device company that focuses on the management of diabetes for patients and healthcare practitioners. The firm offered Asante Snap insulin pump system (Snap system), a pump for individuals starting insulin pump therapy and for existing pumpers. The company was founded by James L. Peterson in 2006 and was headquartered in Sunnyvale, CA.

Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.

Zymenex Holding A/S engages in the research and development of therapeutics for life threatening diseases. The company is headquartered in Hillerod, Denmark.

Sunstone Capital A/S (Sunstone) is an independent venture capital firm headquartered in Copenhagen, Denmark. The firm was founded in 2007 by Peter Benson, Sten Verland, and Søren Lemonius, and invests on behalf of a group of institutional investors.

IMIX Holding AB is a holding Swedish company. The private company is based in Växjö, Sweden and has subsidiaries in Finland. The CEO of the company is Per Jonas Salomonson.

Accelator Nordic AB, a holding company, is engaged in the field of life science. It focuses on the development of image software and medical nanotechnology. It operates through its subsidiaries SPAGO Imaging AB, Synthethic MR AB, and PledPharma. The company was founded in March 1993 and is headquartered in Stockholm, Sweden.

Opsona Therapeutics Ltd. operates as a immunology drug development company. It focuses on novel therapeutics and specializes in the prevention and treatment of solid organ transplantation, cancer, diabetes, autoimmune, inflammatory and Alzheimer’s diseases. The firm developed OPN-305, an antibody to reduce pro-inflammatory cytokine production, which is now at the clinical testing phase. The company was founded by Luke O'Neill, Kingston Mills and Dermot Kelleher in 2004 and is headquartered Dublin, Ireland.

Nuevolution AB engages in pharmaceutical and biotechnology discovery. Its activities include research and development, and licensing drugs and treatment of oncology and chronic inflammatory diseases including cancer. It offers the platform Chemetics, which enables discovery of small molecule drug candidates for specific indications addressing target diseases. The company was founded by Henrik Pedersen, Alex Haahr Gouliaev, and Mads Nørregaard-Madsen in May 2001 and is headquartered in Copenhagen, Denmark.

Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.

Hospital Care SA operates as a hospital holding company. The company was founded on February 8, 2017 and is headquartered in Sao Paulo, Brazil.

Adenium Biotech ApS develops and commercializes novel antibiotics for the treatment of multi drug resistant bacterial infections. It focuses on treatment of nosocomial infections, in particular complicated urinary tract infections and hospital or ventilator acquired pneumonia caused by multi drug resistant Gram-negative bacteria. The company offers Arenicin, an anti-microbial peptide against gram-negative pathogens for pneumonia, urinary tract infection, and acinetobacter baumanii. Adenium Biotech was founded by Peter Nordkild on August 24, 2011 and is headquartered in Copenhagen, Denmark.

PainDrainer AB is a Swedish medical technology company that helps people with chronic pain achieve a better quality of life and activity balance. The company is based in Lund, Sweden. The company's app is based on seven categories that have a scientifically proven impact on pain levels. Users can choose what they want to do more of in their lives, and the app helps them achieve their goals. PainDrainer has been shown to have a scientifically documented effect in many clinical studies and is a CE-marked medical technical app. The CEO of the company is Erik Frick.